Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients

Diabetic Medicine

Volumn 31, Issue 11, 2014, Pages 1357-1362

  Kawakita, R ^a   Hosokawa, Y ^a   Fujimaru, R ^a   Tamagawa, N ^b   Urakami, T ^c   Takasawa, K ^d   Moriya, K ^e   Mizuno, H ^f   Maruo, Y ^g   Takuwa, M ^h   Nagasaka, H ^h   Nishi, Y ⁱ   Yamamoto, Y ^j   Aizu, K ^k   Yorifuji, T ^a,b  

^a Children Medical Center   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^h Takarazuka City Hospital   (Japan)

ⁱ ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^j UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^k SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCOKINASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPUTER PROGRAM; DIABETIC NEPHROPATHY; DIET RESTRICTION; EXON; FAMILY; FEMALE; GENE IDENTIFICATION; GLUCOKINASE MATURITY ONSET DIABETES OF THE YOUNG; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFANT; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MICROVASCULAR COMPLICATION; MISSENSE MUTATION; MOLECULAR DIAGNOSTICS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICIAN; AMINO ACID SUBSTITUTION; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DRUG EFFECTS; FAMILY HEALTH; GENE DELETION; GENETIC ASSOCIATION; GENETICS; INCIDENCE; INSULIN RESISTANCE; JAPAN; METABOLISM; MICROVASCULATURE; MIDDLE AGED; MUTATION; PERIPHERAL VASCULAR DISEASES; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FAMILY HEALTH; FEMALE; GENE DELETION; GENETIC ASSOCIATION STUDIES; GLUCOKINASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN RESISTANCE; JAPAN; MALE; MICROVESSELS; MIDDLE AGED; MUTATION; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84925944557     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12487     Document Type: Article

References (18)

1. Velho G, Blanché H, Vaxillaire M, Bellanné-Chantelot C, Pardini VC, Timsit J et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40: 217-224.
2. Murphy R, Ellard S, Hattersley A. Clinical implications of amolecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008; 4: 200-213.
3. Ellard S, Bellanné-Chantelot C. Hattersley AT, European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008; 51: 546-553.
4. Pruhova S, Dusatkova P, Kraml PJ, Kulich M, Prochazkova Z, Broz J et al. Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness. Int J Endocrinol 2013; 2013: 718254.
5. Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 2014; 311: 279-286.
6. Hwang JS, Shin CH, Yang SW, Jung SY, Huh N. Genetic andclinical ofKorean maturity-onset diabetes of the young (MODY) patients. Diabetes Res Clin Pract 2006; 74: 75-81.
7. Ng MC, Cockburn BN, Lindner TH, Yeung VT, Chow CC, So WY et al. Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclearfactor-1 alpha genes in patients with early-onset type 2 diabetes mellitus/MODY. Diabet Med 1999; 16: 956-963.
8. Xu JY, Dan QH, Chan V, Wat NM, Tam S, Tiu SC et al. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. Eur J Hum Genet 2005; 13: 422-427.
9. Iwasaki N, Ohgawara H, Nagahara H, Kawamura M, Bell GI, Omori Y. Characterization of Japanese families with early-onset type 2 (non-insulin dependent) diabetes mellitus and screening for mutations in the glucokinase and mitochondrial tRNA (Leu(UUR)) genes. Acta Diabetol 1995; 32: 17-22.
10. Ma RC, Chan JC. Type 2 diabetes in EastAsians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci 2013; 1281: 64-91.
11. Yorifuji T, Fujimaru R, Hosokawa Y, Tamagawa N, Shiozaki M, Aizu K et al. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus. Pediatr Diabetes 2012; 13: 26-32.
12. Inokuchi M, Hasegawa T, Anzo M, Matsuo N. Standaedized centile curves of body mass index for Japanese children and adolescents based on the 1978-1981 national survey data. Ann Hum Biol 2006; 33: 444-453.
13. World Health Organization and International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediatehyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland: WHO, 2006: 1-3.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
15. Stride A, Vaxillaire M, Tuomi T, Barbetti F, Njølstad PR, Hansen T et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002; 45: 427-435.
16. Steele AM, Wensley KJ, Ellard S, Murphy R, Shepherd M, Colclough K et al. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. PloS One. 2013; 8: e65326.
17. Yamane S, Hara M, Saito E, Kuromori Y, Iwata F, Okada T et al. Is Acanthosis Nigricans can be a Symbol Marker in Screening Program on Childhood Metabolic Syndrome? Its Usefulness and the Limitation. Himan Kenkyu 2012; 18: 33-38 [In Japanese].
18. Sone H, Ito H, Ohashi Y, Akanuma Y, Yamada N. Japan Diabetes Complication Study Group. Obesity and type 2 diabetes in Japanese patients. Lancet 2003; 361: 85.